The 115 Shares of Teleflex Inc. (TFX) are sold by Sit Investment Associates Inc.

The 115 Shares of Teleflex Inc. (TFX) are sold by Sit Investment Associates Inc.

Sit Investment Associates Inc. lowered its stake in Teleflex Inc. (NYSE:TFX) by 15.9% during the second quarter, Holdings Channel reports. The firm owned 610 shares of the medical technology company’s stock after selling 115 shares during the period. Sit Investment Associates Inc.’s holdings in Teleflex were worth $108,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Checchi Capital Advisers LLC boosted its stake in Teleflex by 0.8% in the second quarter. Checchi Capital Advisers LLC now owns 837 shares of the medical technology company’s stock valued at $148,000 after buying an additional 7 shares during the period. Huntington National Bank boosted its stake in Teleflex by 6.5% in the second quarter. Huntington National Bank now owns 820 shares of the medical technology company’s stock valued at $145,000 after buying an additional 50 shares during the period. Louisiana State Employees Retirement System boosted its stake in Teleflex by 0.9% in the second quarter. Louisiana State Employees Retirement System now owns 11,600 shares of the medical technology company’s stock valued at $2,057,000 after buying an additional 100 shares during the period. Commonwealth Equity Services Inc boosted its stake in Teleflex by 4.5% in the first quarter. Commonwealth Equity Services Inc now owns 3,460 shares of the medical technology company’s stock valued at $543,000 after buying an additional 150 shares during the period. Finally, IBM Retirement Fund boosted its stake in Teleflex by 5.6% in the second quarter. IBM Retirement Fund now owns 4,411 shares of the medical technology company’s stock valued at $782,000 after buying an additional 234 shares during the period. Institutional investors and hedge funds own 93.77% of the company’s stock.

Teleflex Inc. (NYSE:TFX) traded up 0.66% on Friday, reaching $168.81. The company’s stock had a trading volume of 370,154 shares. The stock has a 50 day moving average price of $175.13 and a 200-day moving average price of $170.43. The company has a market capitalization of $7.43 billion, a price-to-earnings ratio of 29.96 and a beta of 0.83. Teleflex Inc. has a 1-year low of $123.79 and a 1-year high of $188.79.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, July 28th. The medical technology company reported $1.89 EPS for the quarter, beating the consensus estimate of $1.74 by $0.15. The business had revenue of $473.60 million for the quarter, compared to analysts’ expectations of $468.40 million. Teleflex had a net margin of 14.89% and a return on equity of 15.59%. Teleflex’s revenue was up 4.8% on a year-over-year basis. During the same period in the previous year, the company posted $1.42 EPS. Equities analysts predict that Teleflex Inc. will post $7.33 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 15th. Investors of record on Monday, August 15th were issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 0.81%. The ex-dividend date was Thursday, August 11th. Teleflex’s dividend payout ratio is presently 24.11%.

Several research firms have recently issued reports on TFX. Barclays PLC raised their price objective on Teleflex from $183.00 to $185.00 and gave the stock an “overweight” rating in a report on Friday, July 29th. Jefferies Group raised their price objective on Teleflex from $157.00 to $185.00 and gave the stock a “hold” rating in a report on Friday, July 29th. Leerink Swann lifted their target price on Teleflex from $183.00 to $190.00 and gave the company a “market perform” rating in a report on Friday, July 29th. Finally, Zacks Investment Research upgraded Teleflex from a “hold” rating to a “buy” rating and set a $192.00 target price on the stock in a report on Wednesday, June 29th. Two research analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $171.33.

About Teleflex

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company markets and sells its products to hospitals and healthcare providers, across the world, through a combination of its direct sales force and distributors.

Related posts

Leave a Comment